Material issues identified
Nihon Chouzai Group’s Approach to Materiality (Key Issues)
In fiscal year 2021, the Group identified 21 material issues for the first time and has since worked to address social issues through its business activities while strengthening its management foundation. Subsequently, to further put the Group Philosophy into practice, we reassessed changes in the healthcare environment and society’s expectations, as well as the role the Group should play. In 2026, we redefined our material issues to more effectively contribute to sustainable growth and the resolution of social issues.
In the 2026 review, rather than simply consolidating the previous 21 material issues, we reorganized them into six material issues from the perspective of the key priorities the Group should strategically address through 2030. For each material issue, we established “Our Approach” and linked it to a total of 26 specific initiatives. We will enhance the effectiveness of these initiatives by monitoring and evaluating progress using KPIs. With materiality serving as a common framework connecting our Group Philosophy with our day-to-day business activities, we will work together as a Group to advance these initiatives.
Our Material Issues and Initiatives
| Material Issue | Our Approach | Initiatives |
|---|---|---|
| A. Enhancing Pharmacy Functions to Meet Diversifying Needs | We will respond to changes in the healthcare environment and remain the pharmacy of choice. | ・Strengthen capabilities to meet advanced healthcare needs, including cancer and intractable diseases ・Contribute to community healthcare and strengthen health support functions ・Strengthen capabilities to meet diverse patient needs ・Promote self-medication |
| B. Improving the Quality of Healthcare through Healthcare DX | We will promote DX and create next-generation value in healthcare. | ・Improve patient convenience through the promotion of healthcare DX ・Improve efficiency and safety through the promotion of healthcare DX ・Promote co-creation with other companies and academia ・Improve the quality of healthcare through the use of healthcare data |
| C. Contributing to Sustainable Healthcare | We will support the healthcare infrastructure through a stable supply of pharmaceuticals and healthcare professionals. | ・Promote the appropriate use of pharmaceuticals and ensure their safety ・Strengthen infrastructure functions as a pharmaceutical supply hub ・Conduct research and present findings that contribute to advances in healthcare ・Address cyber risks ・Research, develop, and manufacture high-quality pharmaceuticals ・Contribute to the stable supply of pharmaceuticals ・Contribute through the provision of high-quality healthcare professionals |
| D. Enhancing Human Capital and Organizational Value | We will support employee growth by providing a positive work environment and build a vibrant, sustainable organization. | ・Provide opportunities for growth (expand learning environments and opportunities) ・Promote sustainable organizational growth (ensure diversity) ・Promote sustainable organizational growth (develop succession plans) ・Provide a positive work environment (expand flexible work arrangements and promote health and productivity management) |
| E. Strengthening Governance to Enhance Trust | We will live up to society’s trust by maintaining disciplined, ethical management.. | ・Ensure rigorous risk management and compliance ・Promote supply chain engagement with a focus on human rights and governance ・Ensure appropriate information sharing and build relationships of trust with all stakeholders |
| F. Passing on a Healthy Global Environment to Future Generations | We will fulfill our responsibility to the future through environmental conservation and support for the next generation. | ・Reduce waste and improve resource efficiency at pharmacies, factories, and other facilities ・Implement initiatives toward a decarbonized society ・Promote supply chain engagement with a focus on reducing environmental impact ・Support learning opportunities and career choices for children |
